MedTrace Logo

Psoriatic Arthritis and Psoriasis Treatment Decision Aid

NCT03737045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2026-02-17

No results posted yet for this study

Summary

The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.

Conditions

Interventions

OTHER

Decision Aid

Participants will test decision aid prototypes that are designed to assist them in choosing a medication.

Sponsors & Collaborators

Principal Investigators

  • Alexis Ogdie-Beatty, MD · University of Pennsylvania

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03737045 on ClinicalTrials.gov